{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-070069","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.256694+00:00","generated_at":"2026-05-18T03:22:52.478052+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"DarioHealth shareholders authorize reverse stock split and increase in authorized shares","bullets":["All seven director nominees elected with majority support; Hila Karah received the most 'against' votes (1.98M).","Kesselman & Kesselman (PwC) ratified as independent auditor for FY2025; 40.1M for, 146k against.","Amended 2020 Equity Compensation Plan approved; adds 6% annual share increase and authorizes RSU grants.","Reverse stock split (2:1 to 25:1) authorized; implementation by Sept 15, 2025, at Board's discretion.","Authorized common stock increased from 160M to 400M shares; approved by stockholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-070069","json":"https://secwatch.observer/filing/0001104659-25-070069.json","markdown":"https://secwatch.observer/filing/0001104659-25-070069.md","text":"https://secwatch.observer/filing/0001104659-25-070069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925070069/0001104659-25-070069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465925070069/tm2521560d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T03:22:52.478052+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}